Credit Agricole started coverage on shares of Eli Lilly & Co. (NYSE: LLY) Several other analysts have also recently commented on the stock. Analysts at Jefferies Group reiterated an ?underperform? rating on shares of Eli Lilly & Co. in a research note to investors on Wednesday. They now have a $43.00 price target on the stock, up previously from $36.00. Separately, analysts at Argus raised their price target on shares of Eli Lilly & Co. from $55.00 to $60.00 in a research note to investors on Monday. They now have a ?buy? rating on the stock. Finally, analysts at Bank of America reiterated a ?buy? rating on shares of Eli Lilly & Co. in a research note to investors on Wednesday, January 9th. They now have a $60.00 price target on the stock, up previously from $57.00.
Five research analysts have rated the stock with a buy rating, two have issued an overweight rating, twelve have assigned a hold rating, and two have assigned a sell rating to the stock. The stock has an average rating of ?hold? and an average price target of $53.27. Eli Lilly & Co. opened at 52.93 on Thursday. Eli Lilly & Co. has a 52-week low of $38.30 and a 52-week high of $53.99. The stock?s 50-day moving average is currently $50.03. The company has a market cap of $59.260 billion and a price-to-earnings ratio of 14.36. Eli Lilly & Co. last posted its quarterly earnings results on Wednesday, October 24th. The company reported $0.79 earnings per share for the quarter, missing the analysts? consensus estimate of $0.82 by $0.03. The company?s revenue for the quarter was down 11.5% on a year-over-year basis. Eli Lilly & Co. has set its FY12 guidance at $3.30-3.40 EPS. On average, analysts predict that Eli Lilly & Co. will post $3.33 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, March 8th. Shareholders of record on Friday, February 15th will be given a dividend of $0.49 per share. This represents a $1.96 dividend on an annualized basis and a yield of 3.71%. The ex-dividend date of this dividend is Wednesday, February 13th.
Eli Lilly and Company discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products.